Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. (2016)
Attributed to:
Psilocybin as a treatment for major depression
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(16)30065-7
PubMed Identifier: 27210031
Publication URI: http://europepmc.org/abstract/MED/27210031
Type: Journal Article/Review
Volume: 3
Parent Publication: The lancet. Psychiatry
Issue: 7
ISSN: 2215-0366